A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma

PHASE4CompletedINTERVENTIONAL
Enrollment

621

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Asthma
Interventions
DRUG

Fluticasone Propionate/salmeterol xinofoate 250/50 mcg BID

Fluticasone Propionate/salmeterol xinofoate 250/50 mcg BID

DRUG

Fluticasone propionate 250 mcg BID

Fluticasone propionate 250 mcg BID

Trial Locations (74)

1101

GSK Investigational Site, Quezon City

1425

GSK Investigational Site, Buenos Aires

1602

GSK Investigational Site, Vicente López

1900

GSK Investigational Site, La Plata

4114

GSK Investigational Site, Cavite

4217

GSK Investigational Site, Lipa City

10021

GSK Investigational Site, New York

11023

GSK Investigational Site, Great Neck

13502

GSK Investigational Site, Utica

15241

GSK Investigational Site, Pittsburgh

15243

GSK Investigational Site, Pittsburgh

19107

GSK Investigational Site, Philadelphia

19140

GSK Investigational Site, Philadelphia

20814

GSK Investigational Site, Bethesda

20902

GSK Investigational Site, Wheaton

23225

GSK Investigational Site, Richmond

23229

GSK Investigational Site, Richmond

27262

GSK Investigational Site, High Point

28801

GSK Investigational Site, Asheville

29118

GSK Investigational Site, Orangeburg

29303

GSK Investigational Site, Spartanburg

29309

GSK Investigational Site, Union

29340

GSK Investigational Site, Gaffney

30013

GSK Investigational Site, Conyers

30047

GSK Investigational Site, Lilburn

31904

GSK Investigational Site, Columbus

32308

GSK Investigational Site, Tallahassee

32504

GSK Investigational Site, Pensacola

33134

GSK Investigational Site, Coral Gables

33173

GSK Investigational Site, Miami

33321

GSK Investigational Site, Tamarac

45231

GSK Investigational Site, Cincinnati

46617

GSK Investigational Site, South Bend

48197

GSK Investigational Site, Ypsilanti

53227

GSK Investigational Site, West Allis

59102

GSK Investigational Site, Billings

59718

GSK Investigational Site, Bozeman

63104

GSK Investigational Site, St Louis

68130

GSK Investigational Site, Omaha

70006

GSK Investigational Site, Metairie

72205

GSK Investigational Site, Little Rock

75110

GSK Investigational Site, Corsicana

77030

GSK Investigational Site, Houston

77054

GSK Investigational Site, Houston

78750

GSK Investigational Site, Austin

79925

GSK Investigational Site, El Paso

80206

GSK Investigational Site, Denver

80230

GSK Investigational Site, Denver

80526

GSK Investigational Site, Fort Collins

80528

GSK Investigational Site, Fort Collins

85251

GSK Investigational Site, Scottsdale

92270

GSK Investigational Site, Rancho Mirage

92506

GSK Investigational Site, Riverside

92708

GSK Investigational Site, Fountain Valley

95117

GSK Investigational Site, San Jose

97213

GSK Investigational Site, Portland

97223

GSK Investigational Site, Tigard

98506

GSK Investigational Site, Olympia

41940455

GSK Investigational Site, Salvador

90095-1690

GSK Investigational Site, Los Angeles

06902

GSK Investigational Site, Stamford

08003

GSK Investigational Site, Cherry Hill

02914

GSK Investigational Site, East Providence

02906

GSK Investigational Site, Providence

02909

GSK Investigational Site, Providence

C1424BSF

GSK Investigational Site, Buenos Aires

C1122AAK

GSK Investigational Site, Ciudad Autonoma de Buenos Aires

B6500BWQ

GSK Investigational Site, Nueve de Julio

30130-100

GSK Investigational Site, Belo Horizonte

50670-420

GSK Investigational Site, Recife

90610-000

GSK Investigational Site, Porto Alegre

L4W 1N2

GSK Investigational Site, Mississauga

C1A 5Y9

GSK Investigational Site, Charlottetown

S7K 7H9

GSK Investigational Site, Saskatoon

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY